Clinical trial
Efficacy and Safety of Peginterferon a-2a in Patients of Chronic Hepatitis B With Spontaneous Decline of HBV DNA
NCT01892241 is registered in ClinicalTrials.gov with Third Affiliated Hospital, Sun Yat-Sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Peginterferon a-2a in Patients of Chronic Hepatitis B With Spontaneous Decline of HBV DNA
- Lead sponsor
- Third Affiliated Hospital, Sun Yat-Sen University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- February 28, 2013
- Enrollment
- 74 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
antiviral treatment of chronic hepatitis b